Table 11.
Extent of sequencing and sequence availability by number of surveillance system components and region
| Africa | Asia | Europe | America | Oceania | Grand total | Percentage (%) | |
|---|---|---|---|---|---|---|---|
| Were isolates sequenced? | |||||||
| Full genome sequenced | 20 | 9 | 5 | 2 | 36 | 6·13 | |
| HA and NA | 23 | 15 | 1 | 39 | 6·64 | ||
| HA only | 2 | 10 | 8 | 20 | 3·41 | ||
| NA only | 2 | 2 | 0·34 | ||||
| Not sure to what extent | 4 | 31 | 7 | 3 | 45 | 7·67 | |
| Total of isolates sequenced | 6 | 76 | 41 | 16 | 3 | 142 | 24·19 |
| Not sequenced | 18 | 24 | 45 | 11 | 11 | 109 | 18·57 |
| Unknown | 61 | 128 | 101 | 32 | 14 | 336 | 57·24 |
| Are sequences publicly available? | |||||||
| GenBank | 33 | 8 | 4 | 3 | 48 | 8·18 | |
| GISAID | 11 | 11 | 1·87 | ||||
| Influenza Research database (IRD) | 4 | 4 | 0·68 | ||||
| Other | 5 | 51 | 4 | 5 | 65 | 11·07 | |
| Total of sequences in public domain | 9 | 84 | 23 | 9 | 3 | 128 | 21·77 |
| No | 2 | 3 | 5 | 0·85 | |||
| Unknown | 74 | 141 | 164 | 50 | 25 | 454 | 77·34 |
| Grand total | 85 | 228 | 187 | 59 | 28 | 587 | 100·00 |
GISAID, Global Initiative on Sharing All Influenza Data.